Works matching IS 02724391 AND DT 2021 AND VI 82 AND IP 6

Results: 14

Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio‐renal damage in COVID‐19 infection.

Published in:

Drug Development Research, 2021, v. 82, n. 6, p. 784, doi. 10.1002/ddr.21810

By:

Singh, Yogendra;
Ali, Haider;
Alharbi, Khalid Saad;
Almalki, Waleed Hassan;
Kazmi, Imran;
Al‐Abbasi, Fahad A.;
Anand, Krishnan;
Dureja, Harish;
Singh, Sachin K.;
Thangavelu, Lakshmi;
Chellappan, Dinesh Kumar;
Dua, Kamal;
Gupta, Gaurav

Publication type:

Article

Contribution of N‐heterocycles towards anti‐tubercular drug discovery (2014–2019); predicted and reengineered molecular frameworks.

Published in:

Drug Development Research, 2021, v. 82, n. 6, p. 767, doi. 10.1002/ddr.21809

By:

Atukuri, Dorababu;
Gunjal, Rutu;
Holagundi, Nagaraj;
Korlahalli, Bibiashabi;
Gangannavar, Sanjeevini;
Akkasali, Kirankumar

Publication type:

Article

Therapeutic delivery with V‐amylose.

Published in:

Drug Development Research, 2021, v. 82, n. 6, p. 727, doi. 10.1002/ddr.21804

By:

Prasher, Parteek;
Fatima, Rabab;
Sharma, Mousmee

Publication type:

Article

Potential of enhancer of zeste homolog 2 inhibitors for the treatment of SWI/SNF mutant cancers and tumor microenvironment modulation.

Published in:

Drug Development Research, 2021, v. 82, n. 6, p. 730, doi. 10.1002/ddr.21796

By:

Pyziak, Karolina;
Sroka‐Porada, Agnieszka;
Rzymski, Tomasz;
Dulak, Józef;
Łoboda, Agnieszka

Publication type:

Article

Paeonol protects melanocytes against hydrogen peroxide‐induced oxidative stress through activation of Nrf2 signaling pathway.

Published in:

Drug Development Research, 2021, v. 82, n. 6, p. 861, doi. 10.1002/ddr.21793

By:

Guo, Shanshan;
Zhang, Qiang

Publication type:

Article

Prolyl hydroxylase inhibitor desidustat protects against acute and chronic kidney injury by reducing inflammatory cytokines and oxidative stress.

Published in:

Drug Development Research, 2021, v. 82, n. 6, p. 852, doi. 10.1002/ddr.21792

By:

Joharapurkar, Amit A.;
Patel, Vishal J.;
Kshirsagar, Samadhan G.;
Patel, Maulik S.;
Savsani, Hardikkumar H.;
Jain, Mukul R.

Publication type:

Article

Alpha‐lipoic acid: A promising adjuvant for nonsteroidal anti‐inflammatory drugs therapy with improved efficacy and gastroprotection.

Published in:

Drug Development Research, 2021, v. 82, n. 6, p. 844, doi. 10.1002/ddr.21791

By:

Barut, Elif Nur;
Engin, Seçkin;
Saygın, İsmail;
Kaya‐Yasar, Yesim;
Arici, Seyma;
Sezen, Sena F.

Publication type:

Article

Insights into antimicrobial peptides in fighting anthrax: A review.

Published in:

Drug Development Research, 2021, v. 82, n. 6, p. 754, doi. 10.1002/ddr.21803

By:

Leonard, Theodore Ebenezer;
Siratan, Elsabda;
Hartiadi, Leonny Yulita;
Crystalia, Audrey Amira

Publication type:

Article

Protection of clozapine‐induced oxidative stress and mitochondrial dysfunction by kaempferol in rat cardiomyocytes.

Published in:

Drug Development Research, 2021, v. 82, n. 6, p. 835, doi. 10.1002/ddr.21790

By:

Bakhshii, Saba;
Khezri, Saleh;
Ahangari, Roya;
Jahedsani, Asal;
Salimi, Ahmad

Publication type:

Article

Design, synthesis, and structure–activity relationship study of O‐prenylated 3‐acetylcoumarins as potent inhibitors of soybean 15‐lipoxygenase.

Published in:

Drug Development Research, 2021, v. 82, n. 6, p. 826, doi. 10.1002/ddr.21787

By:

Zerangnasrabad, Sara;
Jabbari, Atena;
Khavari Moghadam, Elahe;
Sadeghian, Hamid;
Seyedi, Seyed Mohammad

Publication type:

Article

Soluble epoxide hydrolase inhibitor trifluoromethoxyphenyl‐3‐(1‐propionylpiperidin‐4‐yl)urea prevents hyperalgesia through regulating NLRC4 inflammasome‐related pro‐inflammatory and anti‐inflammatory signaling pathways in the lipopolysaccharide‐induced pain mouse model

Published in:

Drug Development Research, 2021, v. 82, n. 6, p. 815, doi. 10.1002/ddr.21786

By:

Cagli, Ali;
Senol, Sefika Pinar;
Temiz‐Resitoglu, Meryem;
Guden, Demet Sinem;
Sari, Ayse Nihal;
Sahan‐Firat, Seyhan;
Tunctan, Bahar

Publication type:

Article

A pharmacokinetic study of morphine‐6‐O‐sulfate in rat plasma and brain.

Published in:

Drug Development Research, 2021, v. 82, n. 6, p. 802, doi. 10.1002/ddr.21785

By:

Yadlapalli, Jai Shankar K.;
Albayati, Zaineb A. F.;
Breen, Philip J.;
Dobretsov, Maxim;
Penthala, Narsimha R.;
Hendrickson, Howard P.;
Crooks, Peter A.

Publication type:

Article

In silico design and synthesis of N‐arylalkanyl 2‐naphthamides as a new class of non‐purine xanthine oxidase inhibitors.

Published in:

Drug Development Research, 2021, v. 82, n. 6, p. 789, doi. 10.1002/ddr.21782

By:

Ho, Sheau Ling;
Lin, Ching‐Ting;
Lee, Shoei‐Sheng

Publication type:

Article

Issue Information.

Published in:: Drug Development Research, 2021, v. 82, n. 6, p. 725, doi. 10.1002/ddr.21695
Publication type:: Article